معالجة النخالية الوردية بالإريثرومايسين و الأسيكلوفير: دراسة مقارنة

Authors

  • جمال خدام
  • محمود دلول
  • ديما محمد

Abstract

 

شملت هذه الدراسة (82) مريضاً من مراجعي العيادة الخارجية للأمراض الجلدية في مشفى الأسد الجامعي باللاذقية، الذين شخص لديهم نخالية وردية سريرياً . تم توزيع المرضى إلى ثلاث مجموعات : المجموعة الأولى هي مجموعة الشاهد التي لم تتلق أي علاج، المجموعة الثانية عولجت بالإريثرومايسين فموياً بجرعة 1غ يومياً مقسمة إلى 4 جرعات لمدة أسبوعين(25-أو40 ملغ/كغ مقسمة إلى 4 جرعات عند الأطفال يومياً)، أما المجموعة الثالثة فقد عولجت بالأسيكلوفير فموياً بجرعة 800 ملغ/5 مرات باليوم لمدة 7 أيام . مع التقييم السريري بعد 7 أيام وأسبوعياً حتى الشفاء . أظهرت الدراسة عدم فعالية الإريثرومايسين الفموي في علاج النخالية الوردية، بينما كان الأسيكلوفير عن طريق الفم ذا فائدة  في تسريع شفاء النخالية الوردية .

This study has included 82 consecutive patients with pityriasis rosea, who came to outpatient clinic of Dermatology at the University Al-Assad hospital in Lattakia. The patients were divided into 3 groups: the first is the control group, the second contains the patients treated  with 1g of erythrom- ycin divided into 4-times daily for 2 weeks (or children 25-40mg\kg divided into 4 times daily); the third group of patients is treated with oral acyclovir 800 mg 5-times daily for 1 week. All patients were evaluated clinically after 7 days and weekly until recovery. We have found that erythromycin has no efficacy in pityriasis rosea, while oral acyclovir has a benefit to shorten the duration of pityriasis rosea.

 

Downloads

Published

2019-01-20

How to Cite

1.
خدام ج, دلول م, محمد د. معالجة النخالية الوردية بالإريثرومايسين و الأسيكلوفير: دراسة مقارنة. Tuj-hlth [Internet]. 2019Jan.20 [cited 2024Apr.26];32(4). Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/6735

Issue

Vol. 32 No. 4 (2010): العلوم الصحية

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Most read articles by the same author(s)

1 2 > >>